Shots:
Andrew Menzies-Gow, in a stimulating conversation with PharmaShots, shares the insights from the Phase III MANDARA study that evaluates Fasenra (benralizumab) vs. mepolizumab for patients with relapsing or refractory EGPA
Five out of the 18 abstracts presented by AstraZeneca at ACR were from the MANDARA study. Apart from the positive endpoints of the MANDARA…
Achieving optimal health and wellness in the modern world involves addressing key areas that serve as the foundations of good health. While diet, exercise, stress management, and sleep are commonly recognized as critical components, pharmaceuticals also play an important role for many individuals. Understanding the role of prescription medications in a wellness plan is crucial…
The US FDA has approved 4 NDAs and 2 BLAs in 2021, leading to treatments for patients and advances in the health care industry
The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 61 novel products in 2021
Additionally, last year in 2020, the US FDA…

